Therapeutic Research Protocol Dose: 2 mg Tesamorelin + 300 mcg Ipamorelin Duration: 12 16 weeks Frequency: Daily, evening administration Cycle Interval: 6 8 weeks off before repeating Goal / Description: Higher-dose protocol for visceral fat reduction and IGF-1 elevation studies
We personalize titration and sideeffect management to help you lose weight safely and keep it off
Some medications, such as Ozempic and Trulicity, are covered under the Pharmaceutical Benefits Scheme (PBS) for people with type 2 diabetes who meet certain criteria
Protocol phase 4: maintenance (months 6 through 12 and beyond) Once your tirzepatide dose is stable at maintenance level and your weight loss has begun to plateau, thyroid monitoring can decrease to every 3 to 6 months for the remainder of the first year, then annually if levels remain stable
1683 B1735W 02B Formulation No Gluten, No Yeast, No Wheat, No Milk or Milk Derivatives, No Lactose, No Sugar, No Soy, No Artificial Flavor, No Sodium (less than 5 mg per serving)
